Literature DB >> 182368

Differential beta adrenergic sensitivity of atrial and ventricular tissue assessed by chronotropic, inotropic, and cyclic AMP responses to isoprenaline and dobutamine.

R R Tuttle, C C Hillmann, R E Toomey.   

Abstract

Cat atrial tissue was more sensitive to isoprenaline (USP:isoproterenol) and dobutamine than ventricular tissue. Chronotropic response of atrial strips occurred at lower agonist concentrations than inotropic responses of papillary muscle. Cyclic AMP responses in atrial slices also occurred at lower agonist concentrations and were of much greater magnitude than the cyclic AMP responses in ventricular slices. However, the disporportionately greater sensitivity of atrial tissue was more marked with isoprenaline than with dobutamine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182368     DOI: 10.1093/cvr/10.4.452

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  5 in total

1.  Bretylium and dobutamine in the treatment of coronary artery disease.

Authors:  W H Frishman
Journal:  Bull N Y Acad Med       Date:  1979-09

2.  Stimulation of beta-adrenoceptors by dobutamine in the guinea-pig atrium and tracheal chain.

Authors:  J Wagner; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

3.  The cardiovascular pharmacology of 7-propyl-theo-phylline-dopamine (D4975); comparison with dopamine and dobutamine.

Authors:  D McCaig; J R Parratt
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

Review 4.  Intravenous vasodilator therapy in congestive heart failure.

Authors:  Kourosh Moazemi; Jatinder S Chana; Anna Marie Willard; Abraham G Kocheril
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Selectivity of dobutamine for adrenergic receptor subtypes: in vitro analysis by radioligand binding.

Authors:  R S Williams; T Bishop
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.